WHO ICTRP trial
Bioequivalence study of metformin 500 mg tablets
IRCT20130626013776N107 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20130626013776N107 |
|---|---|
| Public title | Bioequivalence study of metformin 500 mg tablets |
| Scientific title | A study to compare the relative bioavailability of Poursina and Merck tablet formulations of metformin 500 mg in 24 healthy adult volunteers under fasting conditions |
| Primary sponsor | Poursina Pharmaceuticals |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | Bioequivalence |
| Countries | Iran (Islamic Republic of) |
| Conditions | .. |
| Interventions | Intervention 1: Intervention group: Oral administration of a single 500 mg dose of metformin (1 tablet) manufactured by Poursina to healthy volunteers under fasting condition in the morning of the experiment day. Intervention 2… |
| Registration date | Mar 29, 2023 |
| Target size | 24 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: